State Street’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.7M | Buy |
874,176
+66,755
| +8% | +$1.34M | ﹤0.01% | 2366 |
|
|
2025
Q4 | $18.9M | Sell |
807,421
-12,025
| -1% | -$261K | ﹤0.01% | 2297 |
|
|
2025
Q3 | $16.3M | Buy |
819,446
+11,808
| +1% | +$212K | ﹤0.01% | 2350 |
|
|
2025
Q2 | $11.1M | Buy |
807,638
+12,626
| +2% | +$121K | ﹤0.01% | 2539 |
|
|
2025
Q1 | $8.79M | Sell |
795,012
-13,041
| -2% | -$139K | ﹤0.01% | 2613 |
|
|
2024
Q4 | $8.61M | Buy |
808,053
+38,470
| +5% | +$461K | ﹤0.01% | 2712 |
|
|
2024
Q3 | $9.77M | Buy |
769,583
+42,907
| +6% | +$637K | ﹤0.01% | 2624 |
|
|
2024
Q2 | $12.2M | Buy |
726,676
+189,682
| +35% | +$2.7M | ﹤0.01% | 2442 |
|
|
2024
Q1 | $8.05M | Buy |
536,994
+46,163
| +9% | +$755K | ﹤0.01% | 2702 |
|
|
2023
Q4 | $7.36M | Buy |
490,831
+36,727
| +8% | +$477K | ﹤0.01% | 2747 |
|
|
2023
Q3 | $6.36M | Buy |
454,104
+35,059
| +8% | +$563K | ﹤0.01% | 2815 |
|
|
2023
Q2 | $4.34M | Buy |
419,045
+298,823
| +249% | +$3.3M | ﹤0.01% | 3063 |
|
|
2023
Q1 | $1.11M | Buy |
120,222
+7,632
| +7% | +$70.2K | ﹤0.01% | 3499 |
|
|
2022
Q4 | $999K | Buy |
112,590
+10,008
| +10% | +$94.8K | ﹤0.01% | 3557 |
|
|
2022
Q3 | $853K | Sell |
102,582
-33,039
| -24% | -$273K | ﹤0.01% | 3631 |
|
|
2022
Q2 | $1.11M | Sell |
135,621
-412,620
| -75% | -$2.83M | ﹤0.01% | 3608 |
|
|
2022
Q1 | $4.78M | Buy |
548,241
+41,886
| +8% | +$327K | ﹤0.01% | 3205 |
|
|
2021
Q4 | $4.82M | Sell |
506,355
-5,371
| -1% | -$75.7K | ﹤0.01% | 3257 |
|
|
2021
Q3 | $8.61M | Buy |
511,726
+34,468
| +7% | +$546K | ﹤0.01% | 2972 |
|
|
2021
Q2 | $7.29M | Buy |
477,258
+35,919
| +8% | +$649K | ﹤0.01% | 3061 |
|
|
2021
Q1 | $8.6M | Buy |
441,339
+928
| +0.2% | +$19.7K | ﹤0.01% | 2811 |
|
|
2020
Q4 | $7.94M | Buy |
440,411
+26,941
| +7% | +$564K | ﹤0.01% | 2751 |
|
|
2020
Q3 | $7.98M | Sell |
413,470
-11,731
| -3% | -$266K | ﹤0.01% | 2558 |
|
|
2020
Q2 | $11.1M | Buy |
425,201
+29,056
| +7% | +$710K | ﹤0.01% | 2360 |
|
|
2020
Q1 | $7.07M | Sell |
396,145
-15,549
| -4% | -$420K | ﹤0.01% | 2463 |
|
|
2019
Q4 | $13.7M | Buy |
411,694
+23,865
| +6% | +$651K | ﹤0.01% | 2362 |
|
|
2019
Q3 | $9.24M | Buy |
387,829
+22,687
| +6% | +$742K | ﹤0.01% | 2509 |
|
|
2019
Q2 | $13.1M | Buy |
365,142
+288,275
| +375% | +$10.6M | ﹤0.01% | 2355 |
|
|
2019
Q1 | $2.84M | Buy |
76,867
+37,642
| +96% | +$1.58M | ﹤0.01% | 3018 |
|
|
2018
Q4 | $1.69M | Buy |
39,225
+2,665
| +7% | +$120K | ﹤0.01% | 3181 |
|
|
2018
Q3 | $1.73M | Buy |
36,560
+5,400
| +17% | +$251K | ﹤0.01% | 3300 |
|
|
2018
Q2 | $1.55M | Buy |
+31,160
| New | +$1.81M | ﹤0.01% | 3339 |
|
Other funds holding URGN
RI
KCM
JFG
PBA
ACA
